宫颈小水囊扩张与欣普贝生在孕足月妊娠引产中的临床观察

发布时间：2019-01-30 20:35

【摘要】：目的探讨宫颈小水囊与地诺前列酮栓-欣普贝生在孕41周引产中的有效性和安全性。方法选取2013年1月至2014年11月在北京市回民医院孕足月引产的孕妇共160例,将其随机分为宫颈小水囊组(80例)和地诺前列酮栓-欣普贝生组(80例)两组,观察两组孕妇宫颈Bishop评分、临产时间、总产程、分娩方式、产后出血量及新生儿结局。结果两组12h宫颈评分,阴道分娩率,总产程、新生儿体重,新生儿窒息率、产后出血发生率比较,差异均无统计学意义(P0.05)。结论宫颈小水囊与地诺前列酮栓在孕41周引产中比较,效果相似,但宫颈小水囊更经济,且作用温和,并发症少,在临床中值得推广。
[Abstract]:Objective to investigate the efficacy and safety of cervix vesicles and denoprostone suppositories in induction of labor at 41 weeks gestation. Methods from January 2013 to November 2014, 160 pregnant women were randomly divided into two groups: cervix small water capsule group (80 cases) and denoprostone suppositor-Xinpubeishen group (80 cases). The cervical Bishop score, delivery time, total labor process, delivery mode, postpartum bleeding volume and neonatal outcome were observed in the two groups. Results there was no significant difference in cervical score, vaginal delivery rate, total delivery process, neonatal weight, neonatal asphyxia rate and postpartum hemorrhage rate between the two groups (P0.05). Conclusion compared with diloprostone suppository in inducing labor at 41 weeks of gestation, the effect of cervical vesicle is similar, but it is more economical, milder and has fewer complications, so it is worth popularizing in clinic.
【作者单位】：北京市回民医院产科;
【分类号】：R719.3

【参考文献】